BibTex RIS Kaynak Göster

Demographic characteristics of patients with pulmonary thromboembolism

Yıl 2015, , 10 - 15, 10.05.2015
https://doi.org/10.5799/ahinjs.01.2015.01.0478

Öz

Objective: Pulmonary thromboembolism (PTE) is a common disease with high mortality and difficult diagnosis. The incidence in our country cannot be calculated because there is no adequate and regular data. In our study, we aimed to investigate the demographic characteristics, risk factors, incidence, Wells and Geneva scores diagnostic and treatment methods of the patients in our emergency department with a diagnosis of PTE. Methods: Files of the 112 patients who were admitted to Erciyes University Medical Faculty Emergency Department between January 2010 - February 2012 were analyzed retrospectively. Data were analyzed with SPSS 17.0 statistical software. Results: The mean age of patients was 65.02 ± 16.23. Forty-one (36.6%) of the patients were male and 71 (63.4%) were female. The most common complaint of patients was shortness of breath (81.3%), respectively. Immobilization(35.7%) and history of previous surgery (19.6%) were among the risk factors of the patients. Average troponin levels of the patients was 0.13 ± 0.48 ng/L and average d-dimer levels was 12.698.12 ± 8.779.92 µg/L. Geneva scores of the patients were: 4 patients (3.6%) low score, 88 patients (78.6%) medium score and 20 patients (17.9%) high score. Wells Clinical Probability scores of the patients were; 1 patient (0.9%) low probability, 74 patients (66.1%) intermediate probability and 37 patients (33%) high probability. In the treatment of patients; heparin infusion (36.6%), enoxaparin sodium (59.8%) and tPA (3.6%) were used. Conclusion: In spite of improvements in diagnosis and treatment methods, pulmonary embolism diagnosis is stil a problem. The first step to diagnosis in patients with risk factors begin to suspect. J Clin Exp Invest 2015; 6 (1): 10-15 Key words: pulmonary embolism, diagnosis, treatment, demographic characteristics

Kaynakça

  • Yılmaz S, Topçu F, Şen H.S, et al. Combination of
  • Wells clinical score and high D-dimer levels in the in
  • diagnosis of pulmonary embolism. J Clin Exp Invest
  • ;5:557-562.
  • Şen HS, Abakay Ö, Taylan M, et al. The importance of
  • mean platelet volume in early mortality of pulmonary
  • embolism. J Clin Exp Invest 2013;4:298-301.
  • Torbicki A, van Beek E.J.R, Charbonnier B, et al. Task
  • Force Report. Guidelines on Diagnosis and Management
  • of Acute Pulmonary Embolism. Eur Heart J.
  • ;21:1301-1336.
  • Şen HS, Abakay Ö, et al. Current diagnosis and treatment
  • in pulmonary thromboembolism. J Clin Exp Invest
  • ;4:405-410.
  • Erkan L. Pulmoner Tromboembolizm Özel Sayısı. Ed.
  • Numan Numanoglu. Türkiye Klinikleri Gögüs Hastalıkları
  • ;1.
  • Nijkeuter M, Söhne M, Tick LW, et al. The natural
  • course of hemodynamically stable pulmonary embolism.
  • Chest 2007;131:517-523.
  • Yung GL, Fedullo PF. Disorders of the pulmonary circulation
  • Part IX; Pulmonary Thromboembolic Disease
  • in: Fishman A.P, Elias J.A, Fishman J.A, et al. Fishman’s
  • Pulmonary Diseases and Disorders. 4th ed.
  • Philadelphia 2008;2:14.
  • Stein PD, Hull RD, Saltzman HA, et al. Strategy for
  • diagnosis of patients with suspected acute pulmonary
  • embolism. Chest 1993;103:1553-1559.
  • Van B.A, Buller H.R, Huisman M.V, et al. Effectiveness
  • of managing suspected pulmonary embolism using an
  • algorithm combining clinical probability, D-dimer testing,
  • and computed tomography. JAMA 2006;295:172.
  • Tsai AW, Cushman M, Rosamond W.D, et al. Cardiovascular
  • risk factors and venous thromboembolism incidence:
  • the longitudinal investigation of thromboembolism
  • etiology. Arch Intern Med 2002;162:1182-1189.
  • Sangyeub L, Hyecheol J, et al. Clinical characteristics
  • of acute pulmonary thromboembolism in Korea. International
  • Journal of Cardiology 2006;108:84–88.
  • Mashio N, Masahito S, Norikazu Y, et al. Risk factors
  • of acute pulmonary thromboembolism in Japanese
  • patients hospitalized for medical illness: results of a
  • multicenter registry in the Japanese society of pulmonary
  • embolism research. J Thromb Thrombolysis
  • ;21:131-135.
  • Miniati M, Prediletto R, et al. Accuracy of clinical assessment
  • in the diagnosis of pulmonary embolism.
  • Am J Respir Crit Care Med 1999;159:864–871.
  • White RH. The epidemiology of venous thromboembolism.
  • Circulation 2003; 107: I4-I8.
  • Geibel A, Zehender M, et al. Prognostic value of the
  • ECG on admission in patients with acute major pulmonary
  • embolism. Eur Respir J 2005;25:843–848.
  • Güzel A, Yavuz Y, Şişman B, et al. Acil servise baş-
  • vuran pulmoner tromboemboli olgularinin retrospektif
  • olarak değerlendirilmesi. J Academ Emerg Med
  • 034.
  • Kelly J, Rudd A, Lewis RR, et al. Plasma D-dimers in
  • the diagnosis of venous thromboembolism. Arch Intern
  • Med 2002;162:747-756.
  • Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical
  • characteristics, management, and outcomes of
  • patients diagnosed with acute pulmonary embolism in
  • the emergency department. JACC 2011;57:700-706.
  • Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac
  • troponin T monitoring identifies high-risk group of normotensive
  • patients with acute pulmonary embolism.
  • Chest 2003;123:1947-1952.
  • Frémont B, Pacouret G, Jacobi D, et al. Prognostic
  • value of echocardiographic right/left ventricular enddiastolic
  • diameter ratio in patients with acute pulmonary
  • embolism: results from a monocenter registry of
  • patients. Chest 2008;133:358-362.
  • The PIOPED Investigators. Value of the ventilation/
  • perfusion scan in acute pulmonary embolism. Results
  • of the prospective investigation of pulmonary embolism
  • diagnosis (PIOPED). JAMA 1990;263:2753-
  • -
  • Tapson VF. Acute pulmonary embolism. N Engl J Med
  • ;358:1037-1052.
  • Buller HR, Agnelli G, Hull RD, et al. Antithrombotic
  • therapy for venous thromboembolic disease: the Seventh
  • ACCP Conference on Antithrombotic and Thrombolytic
  • Therapy. Chest 2004;126:163-696.

Pulmoner tromboemboli hastalarının demografik özellikleri

Yıl 2015, , 10 - 15, 10.05.2015
https://doi.org/10.5799/ahinjs.01.2015.01.0478

Öz

Amaç: Pulmoner tromboemboli (PTE) sık görülen, tanısında zorlanılan ve mortalitesi yüksek olan bir hastalıktır. Ülkemizdeki sıklığı ise yeterli ve düzenli veri bulunmadığı için hesaplanamamaktadır. Bu çalışmada acil servisimizde PTE tanısı alan hastaların demografik özellikleri, risk faktörleri, insidansı, Wells ve Geneva skorları, tanı ve tedavi yöntemlerini araştırmayı planladık.Yöntemler: Ocak 2010 – Şubat 2012 tarihleri arasında Erciyes Üniversitesi Tıp Fakültesi Acil Servisinde PTE tanısı konulan 112 hastanın dosyaları geriye dönük olarak incelendi. Veriler SPSS 17.0 programı ile değerlendirildi.Bulgular: Hastaların yaş ortalaması 65,02 ± 16,23 yıl idi. Hastaların 41’i (%36,6) erkek, 71’i (%63,4) kadın idi. Hastaların acil servise başvuru şikayetlerinde en sık nefes darlığı (%81,3) idi. Hastaların risk faktörlerinde immobilizasyon (%35,7), geçirilmiş cerrahi hikayesi (%19,6) mevcut idi. Hastaların troponin ortalaması 0,13 ± 0,48 ng/L ve d-dimer ortalaması 8779,92 ± 12698,12 µg/L idi. Hastaların Geneva Skorlamasında; 4 hastanın (%3,6) skoru düşük, 88 hastanın (%78,6) skoru orta ve 20 hastanın (%17,9) skoru yüksek iken Wells Klinik Olasılık Skorlamasında; 1 hastanın (%0,9) skoru düşük olasılıklı, 74 hastanın (%66,1) skoru orta olasılıklı ve 37 hastanın (%33) skoru yüksek olasılıklı idi. Hastaların tedavilerinde; heparin infüzyonu (% 36,6), enoxaparin (%59,8) ve tPA (%3,6) kullanıldı.Sonuç: Pulmoner tromboemboli tanı ve tedavi araçların gelişmesine rağmen tanı koymakta zorlanan bir hastalık olmaya devam etmektedir. Tanı için ilk adım risk faktörleri olan hastalarda şüphelenmekle başlamaktadır

Kaynakça

  • Yılmaz S, Topçu F, Şen H.S, et al. Combination of
  • Wells clinical score and high D-dimer levels in the in
  • diagnosis of pulmonary embolism. J Clin Exp Invest
  • ;5:557-562.
  • Şen HS, Abakay Ö, Taylan M, et al. The importance of
  • mean platelet volume in early mortality of pulmonary
  • embolism. J Clin Exp Invest 2013;4:298-301.
  • Torbicki A, van Beek E.J.R, Charbonnier B, et al. Task
  • Force Report. Guidelines on Diagnosis and Management
  • of Acute Pulmonary Embolism. Eur Heart J.
  • ;21:1301-1336.
  • Şen HS, Abakay Ö, et al. Current diagnosis and treatment
  • in pulmonary thromboembolism. J Clin Exp Invest
  • ;4:405-410.
  • Erkan L. Pulmoner Tromboembolizm Özel Sayısı. Ed.
  • Numan Numanoglu. Türkiye Klinikleri Gögüs Hastalıkları
  • ;1.
  • Nijkeuter M, Söhne M, Tick LW, et al. The natural
  • course of hemodynamically stable pulmonary embolism.
  • Chest 2007;131:517-523.
  • Yung GL, Fedullo PF. Disorders of the pulmonary circulation
  • Part IX; Pulmonary Thromboembolic Disease
  • in: Fishman A.P, Elias J.A, Fishman J.A, et al. Fishman’s
  • Pulmonary Diseases and Disorders. 4th ed.
  • Philadelphia 2008;2:14.
  • Stein PD, Hull RD, Saltzman HA, et al. Strategy for
  • diagnosis of patients with suspected acute pulmonary
  • embolism. Chest 1993;103:1553-1559.
  • Van B.A, Buller H.R, Huisman M.V, et al. Effectiveness
  • of managing suspected pulmonary embolism using an
  • algorithm combining clinical probability, D-dimer testing,
  • and computed tomography. JAMA 2006;295:172.
  • Tsai AW, Cushman M, Rosamond W.D, et al. Cardiovascular
  • risk factors and venous thromboembolism incidence:
  • the longitudinal investigation of thromboembolism
  • etiology. Arch Intern Med 2002;162:1182-1189.
  • Sangyeub L, Hyecheol J, et al. Clinical characteristics
  • of acute pulmonary thromboembolism in Korea. International
  • Journal of Cardiology 2006;108:84–88.
  • Mashio N, Masahito S, Norikazu Y, et al. Risk factors
  • of acute pulmonary thromboembolism in Japanese
  • patients hospitalized for medical illness: results of a
  • multicenter registry in the Japanese society of pulmonary
  • embolism research. J Thromb Thrombolysis
  • ;21:131-135.
  • Miniati M, Prediletto R, et al. Accuracy of clinical assessment
  • in the diagnosis of pulmonary embolism.
  • Am J Respir Crit Care Med 1999;159:864–871.
  • White RH. The epidemiology of venous thromboembolism.
  • Circulation 2003; 107: I4-I8.
  • Geibel A, Zehender M, et al. Prognostic value of the
  • ECG on admission in patients with acute major pulmonary
  • embolism. Eur Respir J 2005;25:843–848.
  • Güzel A, Yavuz Y, Şişman B, et al. Acil servise baş-
  • vuran pulmoner tromboemboli olgularinin retrospektif
  • olarak değerlendirilmesi. J Academ Emerg Med
  • 034.
  • Kelly J, Rudd A, Lewis RR, et al. Plasma D-dimers in
  • the diagnosis of venous thromboembolism. Arch Intern
  • Med 2002;162:747-756.
  • Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical
  • characteristics, management, and outcomes of
  • patients diagnosed with acute pulmonary embolism in
  • the emergency department. JACC 2011;57:700-706.
  • Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac
  • troponin T monitoring identifies high-risk group of normotensive
  • patients with acute pulmonary embolism.
  • Chest 2003;123:1947-1952.
  • Frémont B, Pacouret G, Jacobi D, et al. Prognostic
  • value of echocardiographic right/left ventricular enddiastolic
  • diameter ratio in patients with acute pulmonary
  • embolism: results from a monocenter registry of
  • patients. Chest 2008;133:358-362.
  • The PIOPED Investigators. Value of the ventilation/
  • perfusion scan in acute pulmonary embolism. Results
  • of the prospective investigation of pulmonary embolism
  • diagnosis (PIOPED). JAMA 1990;263:2753-
  • -
  • Tapson VF. Acute pulmonary embolism. N Engl J Med
  • ;358:1037-1052.
  • Buller HR, Agnelli G, Hull RD, et al. Antithrombotic
  • therapy for venous thromboembolic disease: the Seventh
  • ACCP Conference on Antithrombotic and Thrombolytic
  • Therapy. Chest 2004;126:163-696.
Toplam 84 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Araştırma Yazısı
Yazarlar

Ali Duman

Ömer Salt Bu kişi benim

Seda Özkan Bu kişi benim

Polat Durukan Bu kişi benim

Mücahit Avcıl Bu kişi benim

Yayımlanma Tarihi 10 Mayıs 2015
Yayımlandığı Sayı Yıl 2015

Kaynak Göster

APA Duman, A., Salt, Ö., Özkan, S., Durukan, P., vd. (2015). Demographic characteristics of patients with pulmonary thromboembolism. Journal of Clinical and Experimental Investigations, 6(1), 10-15. https://doi.org/10.5799/ahinjs.01.2015.01.0478
AMA Duman A, Salt Ö, Özkan S, Durukan P, Avcıl M. Demographic characteristics of patients with pulmonary thromboembolism. J Clin Exp Invest. Mayıs 2015;6(1):10-15. doi:10.5799/ahinjs.01.2015.01.0478
Chicago Duman, Ali, Ömer Salt, Seda Özkan, Polat Durukan, ve Mücahit Avcıl. “Demographic Characteristics of Patients With Pulmonary Thromboembolism”. Journal of Clinical and Experimental Investigations 6, sy. 1 (Mayıs 2015): 10-15. https://doi.org/10.5799/ahinjs.01.2015.01.0478.
EndNote Duman A, Salt Ö, Özkan S, Durukan P, Avcıl M (01 Mayıs 2015) Demographic characteristics of patients with pulmonary thromboembolism. Journal of Clinical and Experimental Investigations 6 1 10–15.
IEEE A. Duman, Ö. Salt, S. Özkan, P. Durukan, ve M. Avcıl, “Demographic characteristics of patients with pulmonary thromboembolism”, J Clin Exp Invest, c. 6, sy. 1, ss. 10–15, 2015, doi: 10.5799/ahinjs.01.2015.01.0478.
ISNAD Duman, Ali vd. “Demographic Characteristics of Patients With Pulmonary Thromboembolism”. Journal of Clinical and Experimental Investigations 6/1 (Mayıs 2015), 10-15. https://doi.org/10.5799/ahinjs.01.2015.01.0478.
JAMA Duman A, Salt Ö, Özkan S, Durukan P, Avcıl M. Demographic characteristics of patients with pulmonary thromboembolism. J Clin Exp Invest. 2015;6:10–15.
MLA Duman, Ali vd. “Demographic Characteristics of Patients With Pulmonary Thromboembolism”. Journal of Clinical and Experimental Investigations, c. 6, sy. 1, 2015, ss. 10-15, doi:10.5799/ahinjs.01.2015.01.0478.
Vancouver Duman A, Salt Ö, Özkan S, Durukan P, Avcıl M. Demographic characteristics of patients with pulmonary thromboembolism. J Clin Exp Invest. 2015;6(1):10-5.